Answers are grounded in this paper and cite their sources.
Our data support the concept of early screening and treatment of GDM in high-risk patients. More data are needed to examine the optimal time for screening.
No takes yet. Share an insight, caveat, or question.
Bashir et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: